Alzheimer's Disease Genetics Study
NCRAD
National Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD)
3 other identifiers
observational
10,000
1 country
1
Brief Summary
The purpose of the Alzheimer's Disease Genetics Study is to identify the genes that are responsible for causing Alzheimer's Disease (AD). One of the ways in which the risk factor genes for late onset AD can be investigated is by identifying and collecting genetic material from families with multiple members diagnosed with AD or dementia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2002
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2002
CompletedFirst Submitted
Initial submission to the registry
July 14, 2003
CompletedFirst Posted
Study publicly available on registry
July 16, 2003
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 1, 2026
October 1, 2025
April 1, 2025
24.1 years
July 14, 2003
September 26, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Distribute biological specimens to qualified investigators for use in their research studies.
Investigators will analyze the samples and publish de-identified results. These publications will help to further the knowledge in the field of dementia and potentially lead to new therapies and targets for therapies.
Contact investigators annually for an update on progress and publication status.
Eligibility Criteria
Families with two or more members with Alzheimer's disease or dementia
You may qualify if:
- Two living family members diagnosed with AD or other dementia with any age of onset
- Biological samples available
- Fresh blood, or
- Immortalized lymphoblastic cell lines, or
- grams of frozen cerebral cortex; fixed samples are not accepted
- Please note: this study does not include genetic counseling; because no personal identifying information such as name or date of birth is attached to samples, results of individual tests are not available to participants or family members.
You may not qualify if:
- Member of a family that was included in the National Institute of Mental Health AD Genetics Sib Pair collection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Indiana Universitylead
- National Institute on Aging (NIA)collaborator
Study Sites (1)
Participants are being recruited from all over the United States
Nationwide, Indiana, 46202, United States
Related Links
Biospecimen
blood samples, brain tissue, cell lines
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Tatiana M. Foroud, PhD
National Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD), Indiana University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Department Chair
Study Record Dates
First Submitted
July 14, 2003
First Posted
July 16, 2003
Study Start
June 1, 2002
Primary Completion (Estimated)
July 1, 2026
Study Completion (Estimated)
July 1, 2026
Last Updated
October 1, 2025
Record last verified: 2025-04